from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3705c/-

LFCtreatmentdescriptionclass of inhibitor

3.287

Amikacinug/mL Amikacintranslation

0.951

Cap5-10ug/mL Capreomycintranslation

1.508

Rox10-50 ug/mL Roxithromycintranslation

2.075

SM2-5 ug/mL Streptomycintranslation

3.592

Tet5-10 ug/mL Tetracyclinetranslation

0.111

Rif0.2-5ug/mL Rifampicintranscription

0.480

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.787

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.227

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.424

CPZ10-50 ug/mL Chlorpromazinerespiration

1.657

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.043

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.395

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.216

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.663

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.057

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.265

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.913

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.105

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.243

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.144

KCN5-20 ug/mL Potassium cyaniderespiration

1.803

NaN30.2-2 mM Sodium aziderespiration

0.435

Nigericin50 uM Nigericinrespiration

-0.539

TRC10-150 ug/mL Triclosanrespiration

-1.312

TRZ10-25 ug/mL Thioridazinerespiration

-0.950

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.208

menadione6-10 ug/mL Menadionerespiration

0.652

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.025

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.835

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.349

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.151

NRP_1Non-replicating persistence stage 1dosRassociated

-0.269

Amp0.2mg/mL AmpicillincellWall

0.039

Cephalexin20-100 ug/mL CephalexincellWall

-0.119

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.383

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.247

EMB10-20 ug/mL EthambutolcellWall

0.113

Eta12-40 ug/mL EthionamidecellWall

0.054

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.297

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.402

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.438

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.516

BZA0.12 mg/mL BenzamidearomaticAmides

-0.510

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.178

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.073

H2O24 mM hydrogen peroxideDNAdamaging

-0.113

Levo10 ug/mL LevofloxacinDNAdamaging

-0.612

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.322

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.338

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.317

UVUV-irradiationDNAdamaging

2.600

ARP41-4 ug/mL Antitubercular compound ARP4?

0.692

Antimycin12.5-50 ug/mL Antimycin A?

0.265

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.606

PA_110-50 ug/mL Antitubercular compound PA-1?

0.194

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.228

PA8240.2-2 ug/mL PA-824?

-0.726

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.123

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.419

Verapamil50 uM Verapamil?

0.325

mercaptoethanol2 mM 2-Mercaptoethanol?

0.600

methoxatin10-20 ug/mL Methoxatin?